From: No evidence of association between human cytomegalovirus infection and papillary thyroid cancer
BRAF (+) (n = 31) | BRAF (-) (n = 9) | P value | |
---|---|---|---|
Female | 23 (74%) | 5 (56%) | 0.411 |
Age (years) | 46 ± 15 | 40 ± 7 | 0.437 |
Hashimoto’s thyroiditis | 4 (13%) | 2 (22%) | 0.602 |
Body mass index (kg/m2) | 25.1 ± 4.2 | 22.8 ± 1.3 | 0.482 |
Body weight (kg) | 62 ± 13 | 62 ± 1 | 0.725 |
Tumor size (cm) | 3.1 ± 0.9 | 2.1 ± 1.2 | 0.045* |
Extrathyroidal invasion | 25 (81%) | 3 (33%) | 0.012* |
Multifocality | 11 (35%) | 5 (56%) | 0.441 |
Lymphovascular invasion | 9 (29%) | 2 (22%) | 1.000 |
Lymph node metastasis | 23 (74%) | 2 (22%) | 0.008* |
TNM stage | 0.044* | ||
Stage 1 | 16 (52%) | 8 (89%) | |
Stage 2 | 1 (3%) | 0 (0%) | |
Stage 3 | 8 (26%) | 1 (11%) | |
Stage 4 | 6 (19%) | 0 (0%) |